股票 › CORT
Corcept 制药 CORT
美股市值排名 #1650
$72.77 +$1.14 (+1.59%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $72.77 0.00%
开盘$73.60
昨收$71.63
当日区间$72.17 – $74.86
成交量1.41M
市值$7.96B
市盈率（TTM）54.7
股息率–
财报
财报日平均波动±8.2%近16次财报
收涨次数8 / 1650% 的概率
最佳反应+27.3%
最差反应-10.4%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 29 Jul 2026 | After Market | ±12.0% | +27.29% | 超出定价预期 |
| 2026/Q1 | 30 Apr 2026 | After Market | ±8.0% | +10.53% | 超出定价预期 |
| 2025/Q4 | 24 Feb 2026 | After Market | ±10.6% | -0.71% | 符合区间 |
| 2025/Q3 | 4 Nov 2025 | After Market | ±12.6% | +7.81% | 符合区间 |
| 2025/Q2 | 31 Jul 2025 | After Market | ±11.6% | +2.72% | 符合区间 |
| 2025/Q1 | 5 May 2025 | After Market | ±12.1% | -4.33% | 符合区间 |
| 2024/Q4 | 26 Feb 2025 | After Market | ±23.2% | -5.55% | 符合区间 |
| 2024/Q3 | 30 Oct 2024 | After Market | ±18.9% | +4.44% | 符合区间 |
| 2024/Q2 | 29 Jul 2024 | After Market | ±15.0% | -1.12% | 符合区间 |
| 2024/Q1 | 1 May 2024 | After Market | ±13.1% | +4.94% | 符合区间 |
| 2023/Q4 | 15 Feb 2024 | After Market | ±17.8% | -7.15% | 符合区间 |
| 2023/Q3 | 1 Nov 2023 | After Market | ±12.3% | -9.97% | 符合区间 |
| 2023/Q2 | 2 Aug 2023 | After Market | ±8.9% | +24.91% | 超出定价预期 |
| 2023/Q1 | 3 May 2023 | After Market | ±10.9% | +3.90% | 符合区间 |
| 2022/Q4 | 28 Feb 2023 | After Market | ±11.6% | -4.66% | 符合区间 |
| 2022/Q3 | 3 Nov 2022 | After Market | ±11.5% | -10.41% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
营收构成
2026/Q2 季度
按业务线
基本面
最新报告季度：Q2, ended Jun 2026
营收$256.15M+31.7% YoY
营业利润$41.30M+54.8% YoY
净利润$42.99M+22.3% YoY
摊薄每股收益$0.36+24.1% YoY
自由现金流$31.02M-29.9% YoY
经营现金流$33.54M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率98.3%
营业利润率0.8%
净利率6.5%
净资产收益率8.1%
资产收益率6.4%
投入资本回报率6.2%
流动比率2.86
负债/资产比率20.6%
现金及投资$308.20M
总负债$7.50M
净现金（净负债）$300.69M
自由现金流/营收12.9%
暂无评论——快来第一个聊聊 CORT。
登录后参与讨论。